•
Jun 30, 2013

Jazz Pharmaceuticals Q2 2013 Earnings Report

Total Revenue
$208M
Previous year: $130M
+60.8%
EPS
$1.43
Previous year: $1.09
+31.2%
Gross Profit
$183M
Previous year: $114M
+60.5%
Cash and Equivalents
$504M
Previous year: $155M
+226.3%
Total Assets
$2.09B
Previous year: $1.7B
+23.3%

Jazz Pharmaceuticals

Jazz Pharmaceuticals